Back to Search Start Over

Chronic systemic capillary leak syndrome associated with an intravascular large B-cell lymphoma in a patient undergoing hemodialysis: a case report with literature review

Authors :
Keisuke Sunohara
Rie Shimizu
Kazushi Yasuda
Akiko Owaki
Hiroshi Nagaya
Tomohiro Kajiguchi
Shinichiro Inaba
Source :
Renal Replacement Therapy, Vol 7, Iss 1, Pp 1-7 (2021)
Publication Year :
2021
Publisher :
BMC, 2021.

Abstract

Abstract Background Systemic capillary leak syndrome (SCLS) is a rare disorder characterized by hypotension, hemoconcentration, and hypoalbuminemia associated with increased capillary endothelium permeability. Patients with a chronic form of SCLS present with persistent and progressive generalized edema. However, there have been no reports of chronic SCLS in patients undergoing hemodialysis. Herein, we report a case of chronic SCLS associated with an intravascular large B-cell lymphoma (IVLBCL) in a patient undergoing hemodialysis. Case presentation A 71-year-old male had been on hemodialysis for five years due to diabetic nephropathy. Difficulty in body fluid removal was observed during hemodialysis, and the patient was admitted to our hospital due to exacerbated weight gain and lower limb edema. He had elevated serum lactate dehydrogenase (LDH) levels and thrombocytopenia. His blood pressure was low, and his serum brain natriuretic peptide level was relatively low, despite the increase in body fluid volume. His clinical characteristics suggested a chronic form of SCLS. Random skin biopsy revealed IVLBCL; however, the association between IVLBCL and chronic SCLS remained unclear. He underwent chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisolone, followed by rituximab. After the treatment, his serum LDH level decreased, and the difficulty in body fluid removal during hemodialysis improved. The patient’s chronic SCLS seemed to be complicated by IVLBCL. Conclusions Patients with chronic SCLS who are undergoing hemodialysis seem to present with difficulties in fluid removal. The frequency of SCLS complications in cases with malignant lymphomas, including IVLBCL, is considered to be extremely low. However, clinicians should be aware of SCLS as a complication of malignant lymphomas.

Details

Language :
English
ISSN :
20591381
Volume :
7
Issue :
1
Database :
Directory of Open Access Journals
Journal :
Renal Replacement Therapy
Publication Type :
Academic Journal
Accession number :
edsdoj.f5acc04e525b482da4a82552b58c1704
Document Type :
article
Full Text :
https://doi.org/10.1186/s41100-021-00371-7